Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study

To assess the efficacy of radical surgery combined with recombinant adenoviral human p53 (rAd-p53) gene therapy in treatment of resectable non-small cell lung cancer. A total of 163 patients with resectable NSCLC meeting the inclusion criteria were randomly assigned to two groups: radical surgery al...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncotarget 2017-12, Vol.8 (63), p.107089-107095
Hauptverfasser:	Deng, Bo, Sun, Tianyu, Tang, Bo, Tao, Shaolin, Kang, Poming, Qian, Kai, Jiang, Bin, Li, Kun, Li, Kunkun, Zhou, Jinghai, Wang, Ruwen, Tan, Qunyou
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!